- ICH GCP
- US Clinical Trials Registry
- Researchers
- France
- Acute Myeloid Leukemia
Medical specialists from France tagged as investigators in clinical trials studying Acute Myeloid Leukemia
Total 264 results
-
Micha Srour, MDSeen in:
- Lille, CHRU de Lille
Trials:- NCT03439371 (Principal Investigator)
Conditions: -
N. VeySeen in:
- Marseille, FR-Marseille-IPC
Trials:- NCT04027309 (Principal Investigator)
-
Nicholas Boissel, Dr.Seen in:
- Paris, Hospital Saint-Louis
Trials:- NCT04086264 (Principal Investigator)
Conditions: -
Nicolas BoisselSeen in:
- Paris, CABANNES-HAMY Aurélie
- Paris, Hospital Saint Louis
Trials:- NCT03751072 (Principal Investigator)
- NCT06281847 (Principal Investigator)
-
Nicolas CHOPINSeen in:
- Lyon, Centre Leon Berard
Trials:- NCT04671693 (Sub-Investigator)
-
Norbert Vey, MDSeen in:
- Marseille, Hopital Paoli Calmette
- Marseille, Institut Paoli Calmettes
- Marseille, Institut Paoli Calmettes/Unité d'Hématologie 3
- Marseille, Institut Paoli-Calmettes
Trials:- NCT02619071 (Principal Investigator)
- NCT00411905 (Principal Investigator)
- NCT04243499 (Principal Investigator)
- NCT03503409 (Principal Investigator)
- NCT03744390 (Principal Investigator)
- NCT05181735 (Principal Investigator)
-
Odile BEYNE-RAUZY, MDSeen in:
- Toulouse, CHU Toulouse - IUCT Oncopole
- Toulouse, IUCT Oncopole
- Toulouse, Médecine Interne/IUCT Oncopole
Trials:- NCT04827719 (Principal Investigator)
- NCT03503409 (Principal Investigator)
- NCT03744390 (Principal Investigator)
- NCT03223961 (Principal Investigator)
- NCT03454984 (Principal Investigator)
-
Olivier HERAULT, MD-PhDSeen in:
- Tours, Service d'hématologie biologique-CHRU TOURS
Trials:- NCT05792007 (Principal Investigator)
-
Olivier Hermine, MDSeen in:
- Paris, Hôpital Necker
- Paris, Hôpital Necker - Départementd 'HématologieA dultes
Trials:- NCT04910685 (Principal Investigator)
- NCT02473146 (Principal Investigator)
-
Olivier LegrandSeen in:
- Paris, Hôpital Saint Antoine AP-HP
Trials:- NCT00838240 (Principal Investigator)
Conditions: -
Olivier Tournilhac, MDSeen in:
- Clermont-Ferrand, CHU Estaing
- Clermont-Ferrand, hematology Service - CHU Estaing
Trials:- NCT03439371 (Sub-Investigator)
- NCT01976182 (Sub-Investigator)
-
Olivier TREDANSeen in:
- Lyon, Centre Leon Berard
Trials:- NCT04671693 (Sub-Investigator)
- NCT02029001 (Sub-Investigator)
-
Ollivier LegrandSeen in:
- Paris, Hopital Saint Antoine
- Paris, Hopital Saint-Antoine
Trials:- NCT05260528 (Principal Investigator)
- NCT02473146 (Principal Investigator)
Conditions: -
P.H. RousselotSeen in:
- Chesnay, FR-Le Chesnay cedex-CHVERSAILLES
Trials:- NCT04027309 (Principal Investigator)
-
pascal mossuz, phdSeen in:
- Isere, Grenoble, University Hospital Grenoble
Trials:- NCT02176109 (Principal Investigator)
Conditions: -
Pascal TurlureSeen in:
- Limoges, CHU Limoges
- Limoges, Chu de Limoges
- Limoges, Hôpital Dupuytren
- Limoges, Service de thérapie cellulaire et l'hématologie clinique adulte CHU Limoges
Trials:- NCT05260528 (Principal Investigator)
- NCT04935684 (Principal Investigator)
- NCT05226455 (Principal Investigator)
- NCT02473146 (Principal Investigator)
-
Pascale Blouin, MDSeen in:
- Tours, Service d'onco-hématologie pédiatrique -CHRU Tours
Trials:- NCT05792007 (Sub-Investigator)
-
Paul POUSeen in:
- Lyon, Centre Leon Berard
Trials:- NCT04671693 (Sub-Investigator)
-
Philippe REYSeen in:
- Lyon, Centre Leon Berard
Trials:- NCT04052126 (Sub-Investigator)
- NCT04671693 (Sub-Investigator)
- NCT05947136 (Sub-Investigator)
Conditions:- Quality of Life;
- Lymphoma, Non-Hodgkin;
- Leukemia, Myeloid, Acute;
- Fatigue;
- Exercise;
- Aged;
- Aged, 80 and Over;
- Acute Myeloid Leukemia;
- Hodgkin Disease;
- Osteosarcoma;
- Non Hodgkin Lymphoma;
- Late Effects;
- Ewing's Sarcoma;
- Testicular Germ Cell Tumor Mixed;
- Non-Metastatic Breast Carcinoma;
- Soft Tissue Sarcoma, Adult, Stage IIC;
- Multiple Myeloma;
- Complication
-
Philippe Rousselot, MDSeen in:
- Versailles, CHU Versailles
- Versailles, Centre Hospitalier de Versailles
- Versailles, Hôpital André Mignot
Trials:- NCT04905407 (Principal Investigator)
- NCT03481868 (Principal Investigator)
- NCT04086264 (Principal Investigator)
-
Philippe TOUSSAINTSeen in:
- Lyon, Centre Leon Berard
Trials:- NCT04671693 (Sub-Investigator)
- NCT02029001 (Sub-Investigator)
-
Pierre ArnautouSeen in:
- Clamart, Hôpital d'Instruction des Armée (HIA)
Trials:- NCT05260528 (Principal Investigator)
Conditions: -
Pierre FenauxSeen in:
- Paris, Hôpital Saint Louis
- Paris, Hôpital St Louis
- Vellefaux, Hopital Saint-Louis
Trials:- NCT04797780 (Principal Investigator)
- NCT04905407 (Principal Investigator)
- NCT02649790 (Principal Investigator)
- NCT02473146 (Principal Investigator)
- NCT04827719 (Principal Investigator)
Conditions:- Myelodysplastic Syndromes;
- Acute Myeloid Leukemia;
- Acute Myeloid Leukemia (AML);
- Metastatic Colorectal Cancer (mCRC);
- Metastatic Castration-Resistant Prostate Cancer (mCRPC);
- Relapsed/Refractory Multiple Myeloma (RRMM);
- Higher-Risk Myelodysplastic Syndrome (HR-MDS);
- Newly Diagnosed Intermediate/High-Risk MDS
Clinical Trials on Acute Myeloid Leukemia
-
University of PennsylvaniaActive, not recruitingAcute Myeloid Leukemia, in Relapse | Acute Myeloid Leukemia, Refractory | Acute Myeloid Leukemia, PediatricUnited States
-
National Cancer Institute (NCI)RecruitingAcute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid LeukemiaUnited States
-
Terrence J Bradley, MDImago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New...RecruitingAcute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Acute Myeloid Leukemia, in RelapseUnited States
-
Jacqueline Garcia, MDEli Lilly and CompanyCompletedCombination Merestinib and LY2874455 for Patients With Relapsed or Refractory Acute Myeloid LeukemiaRelapsed Adult Acute Myeloid Leukemia | Refractory Adult Acute Myeloid LeukemiaUnited States
-
University of NebraskaNational Cancer Institute (NCI)Active, not recruitingSecondary Acute Myeloid Leukemia | Therapy-Related Acute Myeloid Leukemia | Adult Acute Myeloid LeukemiaUnited States
-
Massachusetts General HospitalExelixisCompletedRefractory Acute Myeloid Leukemia | Relapsed Acute Myeloid LeukemiaUnited States
-
Bhavana BhatnagarCTI BioPharmaCompletedRecurrent Adult Acute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Untreated Adult Acute Myeloid Leukemia | Therapy-Related Acute Myeloid LeukemiaUnited States
-
Washington University School of MedicineWithdrawnRefractory Acute Myeloid Leukemia | Relapsed Acute Myeloid LeukemiaUnited States
-
C. Babis AndreadisGateway for Cancer Research; AVEO Pharmaceuticals, Inc.TerminatedAcute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Relapsed Acute Myeloid LeukemiaUnited States
-
Xuzhou Medical UniversityRecruitingAcute Myeloid Leukemia, in Relapse | Acute Myeloid Leukemia RefractoryChina